Mithra Pharmaceuticals (MITPF) News Today → The biggest energy story ever? (From Porter & Company) (Ad) Free MITPF Stock Alerts $6.75 0.00 (0.00%) (As of 05/12/2023) Add Compare Share Share HeadlinesStock AnalysisHeadlinesShort InterestStock AnalysisHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMithra updates on offers received in the context of its monetization process and on its Annual Report 2023finance.yahoo.com - April 29 at 8:55 AMMithra secures court protection measures to advance monetization processfinance.yahoo.com - April 22 at 10:35 AMMithra Pharmaceuticals SA MITRAbmorningstar.com - April 17 at 12:13 AMMithra reports full year 2023 financial resultsfinance.yahoo.com - March 8 at 10:08 AMMithra Pharmaceuticals: Mithra announces changes to its executive managementfinanznachrichten.de - March 5 at 8:53 AMMithra Pharmaceuticals: Mithra initiates monetization process, receives bridge loan from existing lendersfinanznachrichten.de - March 5 at 8:53 AMMithra announces changes to its executive managementfinance.yahoo.com - March 5 at 8:53 AMMithra initiates monetization process, receives bridge loan from existing lendersfinance.yahoo.com - March 5 at 8:53 AMMithra announces changes to its executive managementfinance.yahoo.com - March 5 at 8:53 AMDONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phasefinance.yahoo.com - February 29 at 9:27 AMMithra Pharmaceuticals: Mithra updates on cash positionfinanznachrichten.de - February 6 at 2:02 AMMithra updates on cash positionfinance.yahoo.com - February 6 at 2:02 AMMithra Pharmaceuticals S.A.barrons.com - January 19 at 6:32 PMMithra Pharmaceuticals SA MITRAmorningstar.com - January 17 at 9:03 AMMithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israelfinance.yahoo.com - December 21 at 2:22 PMMithra Pharmaceuticals: Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patientsfinanznachrichten.de - December 20 at 1:31 PMMithra Completes Pediatric Study of ESTELLE® in Adolescent Patientsfinance.yahoo.com - December 20 at 1:31 PMMithra Reports Positive Review From DSMB On European Phase 3 Program For DONESTAmarkets.businessinsider.com - December 18 at 9:49 AMMithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trialfinance.yahoo.com - December 18 at 9:49 AMMithra: Gedeon Richter To Have Commercial Rights For ESTELLE, DONESTA In Chinamarkets.businessinsider.com - December 4 at 9:11 AMMithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in Chinafinance.yahoo.com - December 4 at 9:11 AMMithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United Statesfinance.yahoo.com - November 30 at 10:07 AMMithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdamfinance.yahoo.com - November 28 at 3:45 PMMithra’s NEXTSTELLIS® granted additional patent in the United Statesfinance.yahoo.com - November 7 at 9:26 AMMithra releases invitation to its extraordinary securities holders’ meetingfinance.yahoo.com - November 6 at 5:52 PMMithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreementfinance.yahoo.com - October 23 at 7:47 AMMithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meetingfinance.yahoo.com - October 17 at 10:35 AMShareholder Revolt Looms at Mithra as Board Members’ Mandates Challengedmsn.com - October 12 at 1:31 AMMithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World Congressfinance.yahoo.com - October 10 at 1:27 PMMithra Provides an Update in the Context of Recent Market Developmentsfinance.yahoo.com - October 5 at 5:28 AMJagan Mohan Reddy to release Vahana Mithra aid todaymsn.com - September 29 at 12:34 AMMithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen at NAMS 2023finance.yahoo.com - September 27 at 1:35 AMMithra Financial Results for First-Half 2023finance.yahoo.com - September 26 at 10:34 AMMithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CESTfinance.yahoo.com - September 21 at 12:59 PMInformation on the total number of voting rights (denominator)finance.yahoo.com - September 21 at 12:59 PMMithra Pharmaceuticals SA (MITPF)finance.yahoo.com - September 16 at 4:44 AMMithra Pharmaceuticals: Publication of a Transparency Notification Received from Armistice Capital, LLCfinanznachrichten.de - September 12 at 4:26 PMPublication of a Transparency Notification Received from Armistice Capital, LLCfinance.yahoo.com - September 12 at 4:26 PMMithra Pharmaceuticals: Letter to Shareholders and Corporate Updatefinanznachrichten.de - September 11 at 2:26 AMDEGROOF PETERCAM Maintains Mithra Pharmaceuticals (EBR:MITRA) Buy Recommendationnasdaq.com - August 31 at 6:39 PMKBC SECURITIES Downgrades Mithra Pharmaceuticals (EBR:MITRA)nasdaq.com - August 31 at 6:39 PMMithra completes EUR 20 million private placement in equity Update of total number of voting rights (denominator)finance.yahoo.com - August 28 at 12:39 PMMithra prices private placement to raise EUR 20 million in equityfinance.yahoo.com - August 24 at 2:54 AMMithra prices private placement to raise EUR 20 million in equityfinance.yahoo.com - August 24 at 2:54 AMMithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta®finance.yahoo.com - August 8 at 10:05 AMMithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreementfinance.yahoo.com - August 3 at 11:16 AMMithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canadafinance.yahoo.com - July 31 at 11:14 AMMithra Pharmaceuticals: Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025finanznachrichten.de - July 19 at 12:11 AMNotice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025finance.yahoo.com - July 17 at 12:13 PMNotice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025finance.yahoo.com - July 17 at 12:13 PM Get Mithra Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MITPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now MITPF Media Mentions By Week MITPF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MITPF News Sentiment▼1.080.33▲Average Medical News Sentiment MITPF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MITPF Articles This Week▼11▲MITPF Articles Average Week Get Mithra Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MITPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TGIFF News Today FFNTF News Today ABSCF News Today ACRDF News Today ACRHF News Today ALEAF News Today LBTSF News Today AZFL News Today ERBB News Today AVTBF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MITPF) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsA once-in-a-century investment opportunityStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsYour bank is lying to you.MyBankTracker Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mithra Pharmaceuticals SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
